AMEX · Biotechnology

Palatin Technologies, Inc. (PTN) Stock

$5.11 -7.26% AMEX: PTN Healthcare

Valuation

MetricValue
Price$5.11
Market Cap$9.10M
P/E Ratio-1.81
P/B Ratio5.56
P/S Ratio1.28
EPS (TTM)$-2.46
52-Week High$31.00
52-Week Low$5.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-115.00%
ROA-98.29%
ROCE-128.38%
Gross Margin99.76%
Operating Margin-50.60%
Net Margin-63.54%
Debt/Equity0.03
Current Ratio0.38

Annual Financials (USD)

Metric20222023202420252026
Revenue$1.0M$5.0M$4.0M$0$13.0M
Operating Profit$-37.0M$-32.0M$-22.0M$-17.0M$-9.0M
Net Profit$-36.0M$-24.0M$-30.0M$-17.0M$-8.0M
EPS$-3.79$-2.21$-2.02$-32.15$-2.96
Op Margin-2491.6%-668.8%-501.0%—-65.7%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$36.0M$18.0M$11.0M$3.0M$9.0M
Total Liabilities$20.0M$20.0M$11.0M$8.0M$2.0M
Cash$30.0M$8.0M$10.0M$3.0M$7.0M
Borrowings$1.0M$1.0M$1.0M$0$0

Latest News

Top Premarket Gainers MT Newswires · Jun 29, 2026 Palatin Technologies to Transfer Listing to Nasdaq MT Newswires · May 18, 2026 Palatin to Begin Trading on Nasdaq Stock Exchange PR Newswire · May 18, 2026 Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ... GuruFocus.com · May 13, 2026 Transcript: Palatin Techs Q3 2026 Earnings Conference Call Benzinga · May 13, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$-30.0M$-28.0M$-31.0M$-21.0M$-14.0M
Investing Cash Flow$-1.0M$-4.0M$12.0M$3.0M$0
Financing Cash Flow$0$0$6.0M$3.0M$0
Net Cash Flow$-30.0M$-22.0M$2.0M$-7.0M$5.0M
Free Cash Flow$-30.0M$-29.0M$-32.0M$-21.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-1.14
FCF Yield-80.54%
Quick Ratio4.61
Interest Coverage-1288.77
Return 1Y36.15%
Return 3Y-91.92%
Return 5Y-98.66%

Ownership

Insiders Held7.86%
Institutions Held55.58%
Institutions Float Held60.32%
Institutional HolderSharesReport Date
Driehaus Capital Management, LLC166,7132026-03-31
Janus Henderson Group PLC140,0002026-03-31
Logos Global Management LP140,0002026-03-31
RA Capital Management, L.P.70,0002026-03-31
Perceptive Advisors Llc61,9452026-03-31

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is led by CEO Carl Spana, employs 30 people, headquartered in US, publicly traded since 1997.

Palatin Technologies, Inc. (PTN) stock trades at $5.11 with a market capitalization of $9.10M. The stock is valued at a negative price-to-earnings (P/E) ratio of -1.81, reflecting a net loss over the last twelve months, price-to-book of 5.56, price-to-sales of 1.28. Over the past 52 weeks the stock has ranged between $5.00 and $31.00, and currently trades 83.5% below its 52-week high.

On profitability, Palatin Technologies, Inc. generates a return on equity (ROE) of -115.00% (negative, reflecting a net loss), return on capital employed of -128.38%, an operating margin of -50.60%, a net profit margin of -63.54%.

Palatin Technologies, Inc. by the numbers, 2017–2026

Between 2017 and 2026 Palatin Technologies, Inc. reported revenue of $45.0M rising to $13.0M, a change of -71.1% across 10 years. Compounded, revenue has grown —% a year over five years, 37.5% over three, —% over the last twelve months. Net profit rose to $-8.0M.

Operating margin went from -23.6% in 2017 to -65.7% in 2026, a fall of 42.1 percentage points. The most recent net margin is -63.54%. On a trailing twelve-month basis to Jun '26, revenue is $13.0M and net profit $-7.0M.

Borrowings fell from $14.0M to $0, cash from operations was $-14.0M in the latest year, positive in 3 of the last 10.

Return on equity has averaged 226.5% over five years, and was -114.3% in the most recent year.

The share price itself has compounded at -55.3% a year over five years, -51.5% over three, 150.0% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Palatin Technologies, Inc. (PTN) — frequently asked questions

What is Palatin Technologies, Inc. (PTN) stock price today?

Palatin Technologies, Inc. (PTN) is currently trading at $5.11, down 7.26% today.

What is PTN P/E ratio?

Palatin Technologies, Inc.'s P/E ratio is -1.81. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is PTN return on equity (ROE)?

Palatin Technologies, Inc.'s return on equity (ROE) is -115.00%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Palatin Technologies, Inc.'s market cap?

Palatin Technologies, Inc. has a market capitalization of $9.10M.

Does PTN pay a dividend?

Palatin Technologies, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does PTN carry?

Palatin Technologies, Inc. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is PTN's profit margin?

Palatin Technologies, Inc. reports a net profit margin of -63.54% — the share of revenue left after every cost, including tax and interest.

What sector is PTN in?

Palatin Technologies, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is PTN listed on?

Palatin Technologies, Inc. trades on AMEX under the ticker PTN.

What is PTN's 52-week range?

Over the last year Palatin Technologies, Inc. has traded between $5.00 and $31.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens PTN currently matches

On the figures above, Palatin Technologies, Inc. passes the filters for 3 of our ready-made screens, among them Day Losers Stocks, Debt Free Stocks Under $100, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Day Losers StocksDebt Free Stocks Under $100Nano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.